Medical Marijuana, Inc. Subsidiary Phyto Animal Health to Exhibit and Speak at CBD Expo West

SAN DIEGO, Sept. 18, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health will be exhibiting its products and speaking on a featured expert panel at CBD Expo West in Anaheim, CA on September 21-22.

CBD Expo West, hosted at the Marriott Anaheim, is the first and only show dedicated entirely to CBD. The event will feature more than 60 exhibitors, along with a large lineup of presentations and panel discussions featuring experts in the production, distribution and sale of CBD products. CBD Expo West will also showcase a Pet CBD pavilion, which will focus exclusively on pet products within the cannabidiol (CBD) industry.

During the event, Phyto Animal Health will be exhibiting its line of cannabidiol (CBD) hemp oil supplements including tinctures, treats and concentrates for cats, dogs and horses. Additionally, Phyto Animal Health Chief Executive Officer Ian Quinn and Phyto Animal Health Veterinary Advisory Board Member Dr. Robert Klostermann will speak on the panel "My Dog Ate it: Vets, Pets, & CBD," which will cover the benefits of CBD for pets as well as the similarities and differences in how CBD affects the endogenous cannabinoid system of both dogs and humans.

"We are excited Phyto Animal Health is able to exhibit and speak at such a relevant event and raise awareness of the many therapeutic uses of CBD for pets that have been researched by top veterinarians," said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. "Our company always prioritizes networking at top industry events and educating consumers as best as possible." 

A recent study by The Brightfield Group found the cannabidiol (CBD) industry nearly doubled between 2017 and 2018 alone and is expected to grow exponentially to become a nearly $22 billion market over the next five years.

"We are thrilled to have an opportunity to speak on an educational panel about the therapeutic effect of CBD for animals," said Phyto Animal Health Chief Executive Officer Ian Quinn. "Our company is passionate about creating top-quality CBD hemp oil products using eco-friendly practices and we are excited to connect with consumers and colleagues at this year's CBD Expo West."

About Phyto Animal Health
As a company that cares about the health and wellbeing of all animals, Phyto Animal Health also cares about the earth. Using the least amount of water and other resources to create its products, the Company aims to leave the smallest footprint possible while helping provide cats, dogs and horses with the nutritional support they need to have outstanding mental and physical health.

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer CMW Media
P. 858-264-6600
[email protected]
www.cmwmedia.com

SOURCE Medical Marijuana, Inc.